EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression

Jian Kang, Stefano Gallucci, Junqi Pan, Jonathan S Oakhill, Elaine Sanij

Frontiers in Cell and Developmental Biology · 31.10.2024 · 12

DOI: 10.3389/fcell.2024.1449543 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 31.10.2024. Verfasst von Jian Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: St Vincent's Institute of Medical Research, Melbourne, VIC, Australia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STK11 (serine-threonine kinase 11), also known as LKB1 (liver kinase B1) is a highly conserved master kinase that regulates cellular metabolism and polarity through a complex signaling network involving AMPK and 12 other AMPK-related kinases. Germline mutations in LKB1 have been causatively linked to Peutz-Jeghers Syndrome (PJS), an autosomal dominant hereditary disease with high cancer susceptibility. The identification of inactivating somatic mutations in LKB1 in different types of cancer further supports its tumor suppressive role. Deleterious mutations in LKB1 are frequently observed in patients with epithelial ovarian cancer. However, its inconsistent effects on tumorigenesis and cancer progression suggest that its functional impact is genetic context-dependent, requiring cooperation with other oncogenic lesions. In this review, we summarize the pleiotropic functions of LKB1 and how its altered activity in cancer cells is linked to oncogenic proliferation and growth, metastasis, metabolic reprogramming, genomic instability, and immune modulation. We also review the current mechanistic understandings of this master kinase as well as therapeutic implications with particular focus on the effects of LKB1 deficiency in ovarian cancer pathogenesis. Lastly, we discuss whether LKB1 deficiency can be exploited as an Achilles heel in ovarian cancer.

Schlagwörter

Stichwörter der Autor:innen

LKB1STK11cancer biologycancer signalingimmunotherapymetabolismovarian cancertargeted therapy

Autor:innen und Institutionen

  • St Vincent's Institute of Medical Research, Melbourne, VIC, Australia.
  • Department of Medicine-St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.
  • Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.
  • Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Zitieren

APA

Kang, J., Gallucci, S., Pan, J., Oakhill, J. S., & Sanij, E. (2024). The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1449543

Vancouver

Kang J, Gallucci S, Pan J, Oakhill JS, Sanij E. The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1449543

BibTeX
@article{Kang2024,
  author = {Kang, Jian and Gallucci, Stefano and Pan, Junqi and Oakhill, Jonathan S and Sanij, Elaine},
  title = {The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1449543}
}
Kostenlos starten →